HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luca Szalontay Selected Research

Luca Szalontay Research Topics

Disease

24Neoplasms (Cancer)
10/2022 - 08/2009
5Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
06/2013 - 03/2011
4Prostatic Neoplasms (Prostate Cancer)
01/2017 - 03/2011
3Adenocarcinoma
01/2017 - 02/2012
3Triple Negative Breast Neoplasms
11/2014 - 10/2009
3Glioblastoma (Glioblastoma Multiforme)
01/2014 - 03/2013
3Neoplasm Metastasis (Metastasis)
12/2013 - 10/2010
3Colonic Neoplasms (Colon Cancer)
11/2012 - 10/2009
2Myocardial Infarction
01/2015 - 02/2014
2Ischemia
02/2005 - 12/2004
2Hypokinesia (Bradykinesia)
12/2004 - 05/2004
2Parkinson Disease (Parkinson's Disease)
12/2004 - 05/2004
1Medulloblastoma
01/2020
1Renal Cell Carcinoma (Grawitz Tumor)
01/2017
1Lymphoma (Lymphomas)
01/2017
1Heart Failure
01/2015
1Melanoma (Melanoma, Malignant)
01/2014
1Weight Loss (Weight Reduction)
06/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2013
1Liver Neoplasms (Liver Cancer)
10/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
07/2012
1Lower Urinary Tract Symptoms
04/2012
1Ovarian Neoplasms (Ovarian Cancer)
02/2012
1Acromegaly
01/2012
1Adenoma (Adenomas)
01/2012
1Colorectal Neoplasms (Colorectal Cancer)
08/2010
1Leukemia
08/2010
1Carcinoma (Carcinomatosis)
08/2010
1Lung Neoplasms (Lung Cancer)
09/2009
1Breast Neoplasms (Breast Cancer)
08/2009
1Hypoxia (Hypoxemia)
02/2005
1Infarction (Infarctions)
12/2004

Drug/Important Bio-Agent (IBA)

11Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
01/2015 - 10/2009
9Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2014 - 10/2009
7somatotropin releasing hormone receptorIBA
01/2017 - 10/2010
7Doxorubicin (Adriamycin)FDA LinkGeneric
11/2014 - 08/2009
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2013 - 03/2011
5PhAcTyr(1)- Arg(2)- P(H)e(4- CL)(6)- Ala(8)- Tyr(Me)(10)- His(11)- Abu(15)- His(20)- Nle(27)- Arg(28)- HLCr(29)- GHRH(1-29)NH2IBA
06/2013 - 10/2009
5Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2013 - 08/2009
4lysine(6)-doxorubicin LHRHIBA
06/2014 - 07/2012
4cetrorelix (Cetrotide)FDA Link
06/2013 - 10/2009
3Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA
01/2017 - 02/2012
3LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
06/2014 - 07/2012
3Gastrin-Releasing PeptideIBA
02/2013 - 07/2012
3Somatostatin Receptors (Somatostatin Receptor)IBA
02/2013 - 08/2009
3Peptides (Polypeptides)IBA
01/2012 - 08/2009
3RC 121IBA
08/2010 - 08/2009
3Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
12/2004 - 05/2004
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2013 - 02/2012
2Testosterone (Sustanon)FDA Link
06/2013 - 04/2012
2CytokinesIBA
03/2013 - 05/2011
2Fluorouracil (Carac)FDA LinkGeneric
11/2012 - 07/2012
2Irinotecan (Camptosar)FDA LinkGeneric
11/2012 - 07/2012
2Cytotoxins (Cytolysins)IBA
11/2012 - 07/2012
2Proteins (Proteins, Gene)FDA Link
10/2012 - 01/2012
2BombesinIBA
10/2012 - 07/2012
2Hca(6)-Leu(13)-psi(CH2N)-Tac(14)- bombesin(6-14)IBA
10/2012 - 07/2012
2AndrogensIBA
04/2012 - 01/2012
2Messenger RNA (mRNA)IBA
10/2009 - 09/2009
1Cell-Free Nucleic AcidsIBA
10/2022
1Human Growth Hormone (Saizen)FDA LinkGeneric
01/2017
1Hormones (Hormone)IBA
01/2017
1N-Me-Tyr1,D-Ala2,Asn8,Arg29-NHCH3-JI-38IBA
02/2014
1MR 356IBA
02/2014
1JI-38IBA
02/2014
1Pharmaceutical PreparationsIBA
01/2014
1Dihydrotachysterol (AT 10)IBA
01/2014
1MIA-690IBA
01/2014
1Metalloproteases (Metalloproteinases)IBA
12/2013
1Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA
12/2013
1CD146 AntigenIBA
12/2013
1S100 Calcium-Binding Protein A4IBA
12/2013
1Tumor Biomarkers (Tumor Markers)IBA
12/2013
1SynucleinsIBA
12/2013
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
12/2013
1Gonadal Steroid Hormones (Sex Hormones)IBA
05/2013
1N- (2- diethylaminoethyl)- N- (2- hydroxy- 2- phenylethyl)- 2,5- dichloroanilineIBA
02/2013
1Cisplatin (Platino)FDA LinkGeneric
11/2012
1gastrin releasing peptide (14-27)IBA
07/2012
1NeuropeptidesIBA
04/2012
1ImmunosorbentsIBA
02/2012
1LigandsIBA
02/2012
1EnzymesIBA
02/2012
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2012
1matrigelIBA
02/2012
1TOR Serine-Threonine KinasesIBA
01/2012
1Phosphotransferases (Kinase)IBA
01/2012
1MZ 4-71IBA
01/2012
1JV 1-36IBA
01/2012
1vapreotideIBA
01/2012
1glutaric acidIBA
08/2009
1Estrogens (Estrogen)FDA Link
08/2009
1AntioxidantsIBA
12/2004

Therapy/Procedure

9Therapeutics
10/2022 - 01/2012
3Drug Therapy (Chemotherapy)
01/2020 - 08/2009
2Castration
06/2014 - 01/2012
1Immunotherapy
01/2020
1Radiotherapy
01/2020
1Injections
10/2009
1Ligation
02/2005